We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+6.27%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$17.9B
AUM Growth
-$597M
(-3.2%)
Cap. Flow
-$1.32B
Cap. Flow
% of AUM
-7.36%
Top 10 Holdings %
Top 10 Hldgs %
8.81%
Holding
1,709
New
345
Increased
450
Reduced
603
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$146M |
| 2 |
Apple
AAPL
|
+$129M |
| 3 |
Tesla
TSLA
|
+$110M |
| 4 |
Medtronic
MDT
|
+$104M |
| 5 |
Verizon
VZ
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$181M |
| 2 |
Microsoft
MSFT
|
+$177M |
| 3 |
Comcast
CMCSA
|
+$173M |
| 4 |
Adobe
ADBE
|
+$163M |
| 5 |
Broadcom
AVGO
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Healthcare | 14.31% |
| 3 | Consumer Discretionary | 12.9% |
| 4 | Industrials | 11.52% |
| 5 | Financials | 10.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNH
526
CNH Industrial
CNH
$17.3B
| $7.34M | 0.04% |
457,220
-123,165
| -21% | -$1.77M |
|
527
CSX Corp
CSX
$92.8B
| $7.32M | 0.04% |
236,132
-2,376,251
| -91% | -$71.5M |
|
528
Goodyear
GT
$1.74B
| $7.31M | 0.04% |
+720,225
| New | +$7.87M |
|
|
MYOV
529
DELISTED
Myovant Sciences Ltd.
MYOV
| $7.3M | 0.04% |
270,935
+141,729
| +110% | +$3.73M |
|
530
BellRing Brands
BRBR
$1.26B
| $7.26M | 0.04% |
283,251
+174,149
| +160% | +$4.19M |
|
531
Cactus
WHD
$5.8B
| $7.21M | 0.04% |
143,404
-87,688
| -38% | -$4.4M |
|
532
Shutterstock
SSTK
$208M
| $7.2M | 0.04% |
136,524
-44,433
| -25% | -$2.26M |
|
533
Transmedics
TMDX
$3.02B
| $7.19M | 0.04% |
116,424
-30,313
| -21% | -$1.61M |
|
534
KeyCorp
KEY
$24.5B
| $7.17M | 0.04% |
411,856
-348,840
| -46% | -$6.14M |
|
|
VRN
535
DELISTED
Veren
VRN
| $7.11M | 0.04% |
+994,277
| New | +$7.38M |
|
536
Acadia Healthcare
ACHC
$2.95B
| $7.11M | 0.04% |
86,349
+28,568
| +49% | +$2.36M |
|
537
United Airlines
UAL
$40.6B
| $7.09M | 0.04% |
188,146
-97,615
| -34% | -$3.96M |
|
538
Amcor
AMCR
$21.5B
| $7.02M | 0.04% |
117,963
+82,146
| +229% | +$4.79M |
|
|
MRTX
539
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $7.01M | 0.04% |
154,620
+130,363
| +537% | +$8.44M |
|
540
Trip.com Group
TCOM
$28.7B
| $7M | 0.04% |
203,349
+141,435
| +228% | +$4.06M |
|
541
Amkor Technology
AMKR
$13.8B
| $6.98M | 0.04% |
291,038
+244,906
| +531% | +$5.67M |
|
542
Hubbell
HUBB
$27.1B
| $6.98M | 0.04% |
29,738
+18,167
| +157% | +$4.36M |
|
543
Nabors Industries
NBR
$1.33B
| $6.97M | 0.04% |
45,005
-23,616
| -34% | -$3.52M |
|
|
EVBG
544
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $6.91M | 0.04% |
233,745
-71,769
| -23% | -$2.2M |
|
545
Gildan
GIL
$10.6B
| $6.91M | 0.04% |
252,081
+520
| +0.2% | +$15.1K |
|
546
Bath & Body Works
BBWI
$3.65B
| $6.9M | 0.04% |
163,800
+49,781
| +44% | +$1.86M |
|
547
Tidewater
TDW
$4.56B
| $6.89M | 0.04% |
187,092
+38,131
| +26% | +$1.16M |
|
548
Lennar Class A
LEN
$20.5B
| $6.87M | 0.04% |
78,453
-8,490
| -10% | -$688K |
|
549
Telefônica Brasil
VIV
$18.5B
| $6.87M | 0.04% |
960,996
+411,542
| +75% | +$3.08M |
|
550
CVR Energy
CVI
$3.52B
| $6.85M | 0.04% |
218,658
-116,301
| -35% | -$4.13M |
|
Similar funds
VAI
Voloridge Investment Management's Q4 2022 Portfolio in Review
As of Q4 2022, Voloridge Investment Management held 1,709 positions worth $17.9B, down 3.2% from $18.5B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
Voloridge Investment Management withdrew a net $1.32B in Q4 2022, closing 311 positions and reducing 603 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $181M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in Edwards Lifesciences worth $142M.
- Voloridge Investment Management's largest Q4 2022 buy was Edwards Lifesciences: 1,898,822 shares worth $142M.
- Voloridge Investment Management added most to Tesla in Q4 2022, an estimated $110M increase.
- Voloridge Investment Management's biggest Q4 2022 reduction was Microsoft, cutting an estimated $177M.
- Voloridge Investment Management fully exited Berkshire Hathaway Class B in Q4 2022, selling an estimated $181M.
- Voloridge Investment Management's ten largest holdings make up 8.8% of its $17.9B portfolio in Q4 2022.
- Voloridge Investment Management opened 345 new positions and closed 311 in Q4 2022.
- Voloridge Investment Management's portfolio value fell 3.2% quarter-over-quarter to $17.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.